Skip to Content

'
Thomas A. Aloia, MD, FACS

Present Title & Affiliation

Primary Appointment

Associate Professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
P. O. Box 3014202
Unit Number: 1484
Houston, TX 77230-1402

Education & Training

Degree-Granting Education

2010 Jessie H. Jones Graduate School of Business, Rice University, Houston, TX, Certificate, Medical and Healthcare Management
1996 University of California-Los Angeles School of Medicine, Los Angeles, CA, MD, Medicine
1992 Cornell University, Ithaca, NY, BA, Biological Sciences

Postgraduate Training

3/2015-8/2015 ACS Ultrasound for Surgeons Certification, National Ultrasound Foundation (NUF) Ultrasound in Surgery Instructor Certification, Houston, TX
5/2012-3/2018 Basic Life Support Training, The University of Texas MD Anderson Cancer Center, Houston, TX
7/2005-6/2006 Clinical Fellowship, Liver Transplantation and Hepatobiliary Surgery, Paul Brousse Hospital, Villejuif, France
7/2003-6/2005 Clinical Fellowship, Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
7/2002-6/2003 Chief Resident, General and Thoracic Surgery, Duke University Medical Center, Durham, NC
7/2000-6/2002 Clinical Residency, General and Thoracic Surgery, Duke University Medical Center, Durham, NC
7/1998-6/2000 Research Fellowship, Thoracic Oncology Laboratory, Duke University Medical Center, Durham, NC
7/1997-6/1998 Clinical Residency, General and Thoracic Surgery, Duke University Medical Center, Durham, NC
7/1996-6/1997 Clinical Internship, General and Thoracic Surgery, Duke University Medical Center, Durham, NC

Board Certifications

9/2004 American Board of Surgery, Recertification Date: 12/2025
3/2007 Certificate in Surgical Oncology, Society of Surgical Oncology

Experience/Service

Administrative Appointments/Responsibilities

Associate Head, Institute for Cancer Care Innovation, Department of Surgical Oncology, Division of Ofc/EVP, Physician-in-Chief, The University of Texas MD Anderson Cancer Center, Houston, TX, 5/2016-present
Surgery Special Assistant for Quality, Division of Surgery, The University of Texas MD Anderson Cancer Center, Physicians Network, Houston, TX, 6/2014-present
Director of Quality and Outcomes, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 6/2014-present
Deputy Chair for Education, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 6/2014-present
Program Director, International Surgical Oncology Fellowship Program, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 6/2014-present
Associate Medical Director, Gastrointestinal Cancer Center, The University of Texas MD Anderson Cancer Center, Houston, TX, 6/2013-present
Program Director, Hepato-Pancreato-Biliary Surgery Fellowship Program, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, 7/2012-present
Surgeon Champion, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center NSQIP Program, Houston, TX, 2011-present

Institutional Committee Activities

Member, The University of Texas MD Anderson Cancer Center, Hospital Practice Committee, 2015-present
Member, The University of Texas MD Anderson Cancer Center, Clinical Education Team, 11/2014-present
Chair, The University of Texas MD Cancer Center, Graduate Medical Education Committee, Budget Subcommittee, 6/2014-6/2017
Member, The University of Texas MD Anderson Cancer Center, Graduate Medical Education Committee, Budget Subcommittee, 12/2013-present
Chair, The University of Texas MD Anderson Cancer Center, EHR Value Measurement Committee, 11/2013-present
Chair, The University of Texas MD Anderson Cancer Center, Division of Surgery Continuous Quality Improvement (CQI) Committee, 9/2013-present
Member, Texas Medical Center, Surgical Quality Advisory Council, 7/2013-present
Member, The University of Texas MD Anderson Cancer Center, Innovative Clinical Care Committee, 5/2013-present
Member, The University of Texas MD Anderson Cancer Center, Quality Planning Committee, 4/2013-present
Chair, The University of Texas MD Anderson Cancer Center Department of Surgical Oncology Grand Rounds, 7/2012-present
Member, The University of Texas MD Anderson Cancer Center Institutional GMEC Committee, 7/2012-present
Member, The University of Texas MD Anderson Cancer Center Medical Record Committee, 1/2012-present
Physician Ambassador, The University of Texas MD Anderson Cancer Center, DoS Physician Executive Steering Committee, 12/2011-present
Member, The University of Texas MD Anderson Cancer Center Institutional Patient Safety Taskforce, 12/2011-present
Provider Ambassador, The University of Texas MD Anderson Cancer Center Physician Steering Committee for the Medicare Electronic Health Record, 11/2011-present
Member, The University of Texas MD Anderson Cancer, Quality College Advisory Group, 1/2011-present
Member, The University of Texas MD Anderson Cancer Center Infection Control Committee, 2011-present

Honors and Awards

2015 Compagnons Hepato-Biliares, Honor Society, Paul Brousse Hospital Alumni
2015 The University of Texas MD Anderson Cancer Center, President's Recognition for Faculty Excellence
2014 The University of Texas MD Anderson Cancer Center, President's Recognition for Faculty Excellence
2013 Executive of the Year, International Association of Administrative Professionals (IAAP)
2013 Radiological Society of North America Education Award, Radiological Society of North America
2013 Society for Surgery of the Alimentary Tract Best Article Award, Journal of Gastrointestinal Surgery
2013 The University of Texas MD Anderson Cancer Center, President's Recognition for Faculty Excellence
2012 Americas Hepato-Pancreato-Biliary Association North South Traveling Fellowship
2012 J. Bradley Aust Award for Best New Member Paper, Western Surgical Association Annual Meeting
2012 The University of Texas MD Anderson Cancer Center Bayer HealthCare Pharmaceuticals, Inc. Mentor Award
2010 American College of Surgeons Australia New Zealand Traveling Fellowship
2009 Dyer and Baucum Health Quality Fellowship at The Methodist Hospital
2009 Society for Surgery of the Alimentary Tract Karen and Josef E. Fischer International Traveling Fellowship Award for Surgeons in Academic Practice
2005 The University of Texas MD Anderson Cancer Center Surgical Oncology Fellowship Award for Excellence in Clinical Practice
2004-2005 The University of Texas MD Anderson Cancer Center Administrative Fellow in Surgical Oncology
2004 The University of Texas MD Anderson Cancer Center Trainee Recognition Day Poster Award for Clinical Research
1999 Southern Thoracic Surgical Association President's Award: Best Scientific Paper
1998-1999 Duke Comprehensive Cancer Center Harry Hutchison Gibson Fellow in Cancer Research
1995 Alpha Omega Alpha, UCLA School of Medicine
1992 Graduation with Distinction in All Subjects, Cornell University

Professional Memberships

AJCC Cancer Staging Committee: Hepatobiliary Subcommittee: Intrahepatic Cholangiocarcinoma Disease Site
Member, 2007-present
American College of Surgeons
Member, 1997-present
American Society for Enhanced Recovery, Washington, DC
Member, 8/2015-present
American Society of Clinical Oncology
Member, 2004-present
Americas Hepato-Pancreato-Biliary Association
Member, 2005-present
Americas Hepato-Pancreato-Biliary Association Program Committee
Chair, 2014-2017
David C. Sabiston Surgical Society
Member, 2003-present
International Hepato-Pancreato-Biliary Association
Member, 2011-present
SAGES SMART Enhanced Recovery Task Force Committee
Member, 2014-present
Society for Surgery of the Alimentary Tract
Member, 2007-present
Society for Surgery of the Alimentary Tract (SSAT) Representative to the Fellowship Council Education Committee
Member, 2013-present
Society for Surgery of the Alimentary Tract Diversity and Inclusion Liaison Committee
Member, 2015-2017
Society for Surgery of the Alimentary Tract PG/CME Committee
Co-Chair, 2015-2016
Society of Surgical Oncology Research Committee
Member, 2013-2015
Society of University Surgeons Executive Council
Councilor-At-Large & Fundraising Chair, 2013-2016
Society of University Surgeons Foundation Board
Councilor-At-Large, 2013-2016
Surgical Biology Club II
Member, 9/2015-present
Texas NSQIP Collaborative
Member, 2015-present
The Fellowship Council Education Curriculum Committee
SSAT Representative, 11/2015-present
Western Surgical Association
Member, 2011-present
Western Surgical Association Membership Committee
Member, 2014-present

Selected Publications

Peer-Reviewed Original Research Articles

1. Schwarz L, Fleming J, Katz M, Lee J, Aloia T, Vauthey N, Conrad C. Total Laparoscopic Central Pancreatectomy with Pancreaticogastrostomy for High Risk Cystic Neoplasm. Ann Surg Oncol. In Press. PMID: 26542586.
2. Shindoh J, de Aretxabala X, Aloia TA, Roa JC, Roa I, Zimmitti G, Javle M, Conrad C, Maru DM, Aoki T, Vigano L, Ribero D, Kokudo N, Capussotti L, Vauthey JN. Tumor Location Is a Strong Predictor of Tumor Progression and Survival in T2 Gallbladder Cancer: An International Multicenter Study. Ann Surg 261(4):733-9, 4/2015. e-Pub 5/2014. PMID: 24854451.
3. Mise Y, Zimmitti G, Shindoh J, Kopetz S, Loyer EM, Andreou A, Cooper AB, Kaur H, Aloia TA, Maru DM, Vauthey JN. RAS Mutations Predict Radiologic and Pathologic Response in Patients Treated with Chemotherapy Before Resection of Colorectal Liver Metastases. Ann Surg Oncol 22(3):834-42, 3/2015. e-Pub 9/2014. PMCID: PMC4318708.
4. Sheu T, Heymach JV, Swisher SG, Rao G, Weinberg JS, Mehran R, McAleer MF, Liao Z, Aloia TA, Gomez DR. Propensity Score-Matched Analysis of Comprehensive Local Therapy for Oligometastatic Non-Small Cell Lung Cancer That Did Not Progress After Front-Line Chemotherapy. Int J Radiat Oncol Biol Phys 90(4):850-7, 11/2014. e-Pub 9/2014. PMID: 25216859.
5. Mise Y, Mehran RJ, Aloia TA, Vauthey JN. Simultaneous lung resection via a transdiaphragmatic approach in patients undergoing liver resection for synchronous liver and lung metastases. Surgery 156(5):1197-203, 11/2014. e-Pub 6/2014. PMCID: PMC4253649.
6. Conrad C, Nedelcu M, Ogiso S, Aloia TA, Vauthey JN, Gayet B. Laparoscopic Intragastric Surgery for Early Gastric Cancer and Gastrointestinal Stromal Tumors. Ann Surg Oncol 21(8):2620, 8/2014. e-Pub 3/2014. PMID: 24647675.
7. Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): A novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol 110(2):107-14, 8/2014. e-Pub 5/2014. PMID: 24846705.
8. Conrad C, Nedelcu M, Ogiso S, Aloia TA, Vauthey JN, Gayet B. Techniques of intragastric laparoscopic surgery. Surg Endosc. e-Pub 8/2014. PMID: 25106714.
9. Aloia TA, Cooper A, Shi W, Vauthey JN, Lee JE. Reoperative Surgery: A Critical Risk Factor for Complications Inadequately Captured by Operative Reporting and Coding of Lysis of Adhesions. J Am Coll Surg 219(1):143-50, 7/2014. e-Pub 3/2014. PMID: 24862888.
10. Cooper AB, Holmes HM, des Bordes JK, Fogelman D, Parker NH, Lee JE, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Role of Neoadjuvant Therapy in the Multimodality Treatment of Older Patients with Pancreatic Cancer. J Am Coll Surg 219(1):111-20, 7/2014. e-Pub 3/2014. PMID: 24856952.
11. Thomas RM, Aloia TA, Truty MJ, Tseng WH, Choi EA, Curley SA, Vauthey JN, Abdalla EK. Treatment sequencing strategy for hepatic epithelioid haemangioendothelioma. HPB (Oxford) 16(7):677-85, 7/2014. e-Pub 12/2013. PMCID: PMC4105907.
12. Aloia TA. Contemplation versus Documentation Before Surgery. Ann Surg 259(6):1038-40, 6/2014. e-Pub 3/2014. PMID: 24646563.
13. Tzeng CW, Cooper AB, Vauthey JN, Curley SA, Aloia TA. Predictors of morbidity and mortality after hepatectomy in elderly patients: analysis of 7621 NSQIP patients. HPB (Oxford) 16(5):459-68, 5/2014. e-Pub 8/2013. PMCID: PMC4008164.
14. Yoon SS, Aloia TA, Haynes AB, Kambadakone A, Kaur H, Vauthey JN, Ferrone CR, Zhu AX, Wo JY, Crane C, Hong TS. Surgical placement of biologic mesh spacers to displace bowel away from unresectable liver tumors followed by delivery of dose-intense radiation therapy. Pract Radiat Oncol 4(3):167-73, May-Jun, 5/2014. e-Pub 8/2013. PMCID: PMC4003410.
15. Huang SY, Aloia TA, Shindoh J, Ensor J, Shaw CM, Loyer EM, Vauthey JN, Wallace MJ. Efficacy and Safety of Portal Vein Embolization for Two-Stage Hepatectomy in Patients with Colorectal Liver Metastasis. J Vasc Interv Radiol 25(4):608-17, 4/2014. e-Pub 12/2013. PMID: 24315549.
16. Javle M, Rashid A, Churi C, Kar S, Zuo M, Eterovic AK, Nogueras-Gonzalez GM, Janku F, Shroff RT, Aloia TA, Vauthey JN, Curley S, Mills G, Roa I. Molecular Characterization of Gallbladder Cancer using Somatic Mutation Profiling. Hum Pathol 45(4):701-8, 4/2014. e-Pub 11/2013. PMCID: PMC4428571.
17. Raoof M, Aloia TA, Vauthey JN, Curley SA. Morbidity and Mortality in 1,174 Patients Undergoing Hepatic Parenchymal Transection Using a Stapler Device. Ann Surg Oncol 21(3):995-1001, 3/2014. e-Pub 11/2013. PMID: 24248530.
18. Tzeng CW, Katz MH, Fleming JB, Lee JE, Pisters PW, Holmes HM, Varadhachary GR, Wolff RA, Abbruzzese JL, Vauthey JN, Aloia TA. Morbidity and Mortality after Pancreaticoduodenectomy in Patients with Borderline Resectable Type C Clinical Classification. J Gastrointest Surg 18(1):146-55; discussion 155-6, 1/2014. e-Pub 10/2013. PMID: 24129825.
19. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Safety and Efficacy of Portal Vein Embolization Before Planned Major or Extended Hepatectomy: An Institutional Experience of 358 Patients. J Gastrointest Surg 18(1):45-51, 1/2014. e-Pub 10/2013. PMID: 24129824.
20. Tzeng CW, Tran Cao HS, Lee JE, Pisters PW, Varadhachary GR, Wolff RA, Abbruzzese JL, Crane CH, Evans DB, Wang H, Abbott DE, Vauthey JN, Aloia TA, Fleming JB, Katz MH. Treatment Sequencing for Resectable Pancreatic Cancer: Influence of Early Metastases and Surgical Complications on Multimodality Therapy Completion and Survival. J Gastrointest Surg 18(1):16-24; discussion 24-5, 1/2014. e-Pub 11/2013. PMID: 24241967.
21. Kaseb AO, Xiao L, Hassan MM, Chae YK, Lee JS, Vauthey JN, Krishnan S, Cheung S, Hassabo HM, Aloia TA, Conrad C, Curley SA, Vierling JM, Jalal P, Raghav K, Wallace M, Rashid A, Abbruzzese JL, Wolff RA, Morris JS. Development and Validation of Insulin-like Growth Factor-1 Score to Assess Hepatic Reserve in Hepatocellular Carcinoma. J Natl Cancer Inst 106(5), 2014. e-Pub 5/2014. PMID: 24815863.
22. Kaseb AO, Shah NN, Hassabo HM, Morris JS, Xiao L, Abaza YM, Soliman K, Lee JS, Vauthey JN, Wallace M, Aloia TA, Curley S, Abbruzzese JL, Hassan MM. Reassessing hepatocellular carcinoma staging in a changing patient population. Oncology 86(2):63-71, 2014. e-Pub 1/2014. PMID: 24401634.
23. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Gupta S, Wallace MJ, Vauthey JN. Portal vein embolization improves rate of resection of extensive colorectal liver metastases without worsening survival. Br J Surg 100(13):1777-83, 12/2013. PMID: 24227364.
24. Zimmitti G, Vauthey JN, Shindoh J, Tzeng CW, Roses RE, Ribero D, Capussotti L, Giuliante F, Nuzzo G, Aloia TA. Systematic use of an intraoperative air leak test at the time of major liver resection reduces the rate of postoperative biliary complications. J Am Coll Surg 217(6):1028-37, 12/2013. PMID: 24246619.
25. Short MN, Aloia TA, Ho V. The influence of complications on the costs of complex cancer surgery. Cancer. e-Pub 12/2013. PMID: 24382697.
26. Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma? Surg Endosc 27(11):4026-32, 11/2013. e-Pub 6/2013. PMID: 23765427.
27. Tzeng CW, Curley SA, Vauthey JN, Aloia TA. Distinct predictors of pre- versus post-discharge venous thromboembolism after hepatectomy: analysis of 7621 NSQIP patients. HPB (Oxford) 15(10):773-80, 10/2013. e-Pub 7/2013. PMCID: PMC3791116.
28. Das P, Abboud MT, Haque W, Javle M, Kaseb A, Curley SA, Vauthey JN, Aloia TA, Beddar AS, Delclos ME, Krishnan S, Crane CH. Gastric Bleeding After Radiation Therapy for Intrahepatic Cholangiocarcinoma. Pract Radiat Oncol 3(4):344-8, Oct-Dec, 10/2013. e-Pub 12/2012. PMID: 24674408.
29. Peungjesada S, Aloia TA, Kaur H, Marcal L, Choi H, Vauthey JN, Loyer EM. Intrabiliary growth of colorectal liver metastasis: spectrum of imaging findings and implications for surgical management. AJR Am J Roentgenol 201(4):W582-9, 10/2013. PMID: 24059396.
30. Mahajan SN, Ariza-Heredia EJ, Rolston KV, Graviss LS, Feig BW, Aloia TA, Chemaly RF. Perioperative Antimicrobial Prophylaxis for Intra-abdominal Surgery in Patients with Cancer: A Retrospective Study Comparing Ertapenem and Nonertapenem Antibiotics. Ann Surg Oncol. e-Pub 10/2013. PMID: 24114052.
31. Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Radiographic Tumor-Vein Interface as a Predictor of Intraoperative, Pathologic, and Oncologic Outcomes in Resectable and Borderline Resectable Pancreatic Cancer. J Gastrointest Surg. e-Pub 10/2013. PMID: 24129826.
32. Vauthey JN, Zimmitti G, Kopetz SE, Shindoh J, Chen SS, Andreou A, Curley SA, Aloia TA, Maru DM. RAS Mutation Status Predicts Survival and Patterns of Recurrence in Patients Undergoing Hepatectomy for Colorectal Liver Metastases. Ann Surg 258(4):619-27, 10/2013. PMID: 24018645.
33. Kaseb AO, Shindoh J, Patt YZ, Roses RE, Zimmitti G, Lozano RD, Hassan MM, Hassabo HM, Curley SA, Aloia TA, Abbruzzese JL, Vauthey JN. Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma. Cancer 119(18):3334-42, 9/2013. e-Pub 7/2013. PMCID: PMC3775991.
34. Cho SW, Tzeng CW, Johnston WC, Cassera MA, Newell PH, Hammill CW, Wolf RF, Aloia TA, Hansen PD. Neoadjuvant radiation therapy and its impact on complications after pancreaticoduodenectomy for pancreatic cancer: analysis of the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP). HPB (Oxford). e-Pub 9/2013. PMID: 24112766.
35. Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol 20(8):2493-500, 8/2013. e-Pub 2/2013. PMID: 23377564.
36. Tzeng CW, Balachandran A, Ahmad M, Lee JE, Krishnan S, Wang H, Crane CH, Wolff RA, Varadhachary GR, Pisters PW, Aloia TA, Vauthey JN, Fleming JB, Katz MH. Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer. HPB (Oxford). e-Pub 8/2013. PMID: 23991810.
37. Shindoh J, Vauthey JN, Zimmitti G, Curley SA, Huang SY, Mahvash A, Gupta S, Wallace MJ, Aloia TA. Analysis of the Efficacy of Portal Vein Embolization for Patients with Extensive Liver Malignancy and Very Low Future Liver Remnant Volume, Including a Comparison with the Associating Liver Partition with Portal Vein Ligation for Staged Hepatectomy Approach. J Am Coll Surg 217(1):126-33; discussion 133-4, 7/2013. e-Pub 4/2013. PMCID: PMC3880191.
38. Gaber AO, Moore LW, Aloia TA, Suki WN, Jones SL, Graviss EA, Knight RJ, Bass BL. Cross-sectional and Case-Control Analyses of the Association of Kidney Function Staging With Adverse Postoperative Outcomes in General and Vascular Surgery. Ann Surg 258(1):169-77, 7/2013. e-Pub 3/2013. PMID: 23478526.
39. Frenette CT, Boktour M, Burroughs SG, Kaseb A, Aloia TA, Galati J, Gaber AO, Monsour H, Ghobrial RM. Pre-Transplant Utilization of Sorafenib is Not Associated with Increased Complications after Liver Transplantation. Transpl Int 26(7):734-9, 7/2013. e-Pub 5/2013. PMID: 23701126.
40. Tzeng CW, Katz MH, Lee JE, Fleming JB, Pisters PW, Vauthey JN, Aloia TA. Predicting the risks of venous thromboembolism versus post-pancreatectomy haemorrhage: analysis of 13 771 NSQIP patients. HPB (Oxford). e-Pub 7/2013. PMID: 23869628.
41. Landry CS, Lin HY, Phan A, Charnsangavej C, Abdalla EK, Aloia TA, Nicolas Vauthey J, Katz MH, Yao JC, Fleming JB. Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors. World J Surg 37(7):1695-700, 7/2013. PMCID: PMC3881007.
42. Andreou A, Aloia TA, Brouquet A, Dickson PV, Zimmitti G, Maru DM, Kopetz S, Loyer EM, Curley SA, Abdalla EK, Vauthey JN. Margin Status Remains an Important Determinant of Survival after Surgical Resection of Colorectal Liver Metastases in the Era of Modern Chemotherapy. Ann Surg 257(6):1079-88, 6/2013. e-Pub 2/2013. PMCID: PMC3654038.
43. Shindoh J, Andreou A, Aloia TA, Zimmitti G, Lauwers GY, Laurent A, Nagorney DM, Belghiti J, Cherqui D, Poon RT, Kokudo N, Vauthey JN. Microvascular Invasion Does Not Predict Long-Term Survival in Hepatocellular Carcinoma up to 2 cm: Reappraisal of the Staging System for Solitary Tumors. Ann Surg Oncol 20(4):1223-9, 4/2013. e-Pub 11/2012. PMID: 23179993.
44. Badgwell BD, Aloia TA, Garrett J, Chedister G, Miner T, Krouse R. Indicators of symptom improvement and survival in in patients with advanced cancer undergoing palliative surgical consultation. J Surg Oncol 107(4):367-71, 3/2013. e-Pub 8/2012. PMID: 22886727.
45. Schwarz RE, Abdalla EK, Aloia TA, Vauthey JN. AHPBA/SSO/SSAT sponsored consensus conference on the multidisciplinary treatment of colorectal cancer metastases. HPB (Oxford) 15(2):89-90, 2/2013. PMCID: PMC3719913.
46. Shindoh J, Truty MJ, Aloia TA, Curley SA, Zimmitti G, Huang SY, Mahvash A, Gupta S, Wallace MJ, Vauthey JN. Kinetic Growth Rate after Portal Vein Embolization Predicts Posthepatectomy Outcomes: Toward Zero Liver-Related Mortality in Patients with Colorectal Liver Metastases and Small Future Liver Remnant. JACS 216(2):201-9, 2/2013. e-Pub 12/2012. PMID: 23219349.
47. Tzeng CW, Aloia TA, Vauthey JN, Chang GJ, Ellis LM, Feig BW, Curley SA, Skibber JM, Abdalla EK, You YN, Rodriguez-Bigas MA. Morbidity of staged proctectomy after hepatectomy for colorectal cancer: A matched case-control cnalysis. Ann Surg Oncol 20(2):482-90, 2/2013. e-Pub 8/2012. PMID: 22932858.
48. Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN. Selection for Hepatic Resection of Colorectal Liver Metastases: Expert Consensus Statement. HPB (Oxford) 15(2):91-103, 2/2013. PMID: 23297719.
49. Zimmitti G, Roses RE, Andreou A, Shindoh J, Curley SA, Aloia TA, Vauthey JN. Greater Complexity of Liver Surgery is Not Associated with an Increased Incidence of Liver-Related Complications Except for Bile Leak: An Experience with 2,628 Consecutive Resections. J Gastrointest Surg 17(1):57-64; discussion p.64-5, 1/2013. e-Pub 9/2012. PMID: 22956403.
50. Andreou A, Vauthey JN, Cherqui D, Zimmitti G, Ribero D, Truty MJ, Wei SH, Curley SA, Laurent A, Poon RT, Belghiti J, Nagorney DM, Aloia TA, International Cooperative Study Group on Hepatocellular Carcinoma. Improved Long-Term Survival after Major Resection for Hepatocellular Carcinoma: A Multicenter Analysis Based on a New Definition of Major Hepatectomy. J Gastrointest Surg 17(1):66-77, 1/2013. e-Pub 9/2012. PMCID: PMC3880185.
51. Kaseb AO, Shama M, Sahin IH, Nooka A, Hassabo HM, Vauthey JN, Aloia TA, Abbruzzese JL, Subbiah IM, Janku F, Curley S, Hassan MM. Prognostic Indicators and Treatment Outcome in 94 Cases of Fibrolamellar Hepatocellular Carcinoma. Oncology 85(4):197-203, 2013. e-Pub 9/2013. PMID: 24051705.
52. Shindoh J, Loyer EM, Kopetz S, Boonsirikamchai P, Maru DM, Chun YS, Zimmitti G, Curley SA, Charnsangavej C, Aloia TA, Vauthey JN. Optimal Morphologic Response to Preoperative Chemotherapy: An Alternate Outcome End Point before Resection of Hepatic Colorectal Metastases. J Clin Oncol 30(36):4566-72, 12/2012. e-Pub 11/2012. PMCID: PMC3518730.
53. Andreou A, Kopetz S, Maru DM, Chen SS, Zimmitti G, Brouquet A, Shindoh J, Curley SA, Garrett C, Overman MJ, Aloia TA, Vauthey JN. Adjuvant chemotherapy with FOLFOX for primary colorectal cancer is associated with increased somatic gene mutations and inferior survival in patients undergoing hepatectomy for metachronous liver metastases. Ann Surg 256(4):642-50, 10/2012. PMID: 22968062.
54. Vauthey JN, Kopetz S, Aloia TA, Andreou A. KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary. Br J Cancer 107(8):1442-3; author reply 1444, 10/2012. e-Pub 9/2012. PMCID: PMC3494431.
55. Abbott DE, Cantor SB, Hu CY, Aloia TA, You YN, Nguyen S, Chang GJ. Optimizing clinical and economic outcomes of surgical therapy for patients with colorectal cancer and synchronous liver metastases. J Am Coll Surg 215(2):262-70, 8/2012. e-Pub 5/2012. PMID: 22560316.
56. Tzeng CW, Katz MH, Fleming JB, Pisters PW, Lee JE, Abdalla EK, Curley SA, Vauthey JN, Aloia TA. Risk of venous thromboembolism outweighs post-hepatectomy bleeding complications: analysis of 5651 National Surgical Quality Improvement Program patients. HPB (Oxford) 14(8):506-13, 8/2012. e-Pub 5/2012. PMID: 22762398.
57. Andreou A, Brouquet A, Bharathy KG, Perrier ND, Abdalla EK, Curley SA, Glanemann M, Seehofer D, Neuhaus P, Vauthey JN, Aloia TA. Liver resection for liver metastases from nondigestive endocrine cancer: extrahepatic disease burden defines outcome. Surgery. e-Pub 2/2012. PMID: 22306838.
58. Spinks T, Albright HW, Feeley TW, Walters R, Burke TW, Aloia TA, Bruera E, Buzdar A, Foxhall L, Hui D, Summers B, Rodriguez A, Dubois R, Shine KI. Ensuring quality cancer care: A follow-up review of the Institute of Medicine's 10 recommendations for improving the quality of cancer care in America. Cancer. e-Pub 11/2011. PMCID: PMC3272132.
59. Andreou A, Brouquet A, Abdalla EK, Aloia TA, Curley SA, Vauthey JN. Repeat hepatectomy for recurrent colorectal liver metastases is associated with a high survival rate. HPB (Oxford) 13(11):774-82, 11/2011. e-Pub 9/2011. PMCID: PMC3238011.
60. Kaseb AO, Morris JS, Hassan MM, Siddiqui AM, Lin E, Xiao L, Abdalla EK, Vauthey JN, Aloia TA, Krishnan S, Abbruzzese JL. Clinical and prognostic implications of plasma insulin-like growth factor-1 and vascular endothelial growth factor in patients with hepatocellular carcinoma. J Clin Oncol 29(29):3892-9, 10/2011. e-Pub 9/2011. PMCID: PMC3189091.
61. Kaseb AO, Abbruzzese JL, Vauthey JN, Aloia TA, Abdalla EK, Hassan MM, Lin E, Xiao L, El-Deeb AS, Rashid A, Morris JS. I-CLIP: Improved Stratification of Advanced Hepatocellular Carcinoma Patients by Integrating Plasma IGF-1 into CLIP Score. Oncology 80(5-6):373-81, 2011. e-Pub 8/2011. PMCID: PMC3171278.
62. Aloia TA. Predicting adverse outcomes after complex cancer surgery. Ann Surg Oncol 17(9):2260-1, 9/2010. PMCID: PMC2924501.
63. Aloia TA, Knight R, Gaber AO, Ghobrial RM, Goss JA. Analysis of liver transplant outcomes for United Network for Organ Sharing recipients 60 years old or older identifies multiple model for end-stage liver disease-independent prognostic factors. Liver Transpl 16(8):950-9, 8/2010. PMID: 20589647.
64. Aloia TA, Hemming A, Schwartz M. Surgical treatment of hepatocellular cancer: expert consensus conference. HPB (Oxford) 12(5):311-12, 6/2010. PMCID: PMC2951817.
65. Aloia TA, McFadden DW. Candida in pancreatic infection: a clinical experience. The American Surgeon 60:793-96, 1994.
66. Gaber OA, Moore LW, Aloia TA, Suki W, Jones SL, Knight RJ, Bass BL. Change in Glomerular Filtration Rate as a Predictor of Surgical Outcomes. Annals of Surgery. Submitted.
67. Aloia TA. Validation of a modified Child-Pugh score ofr predicitin survival in patients with hepatocellular carcinoma. Submitted.

Invited Articles

1. Aloia TA. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy: Portal Vein Embolization Should Remain the Gold Standard. JAMA Surg 150(10):927-8, 10/2015. e-Pub 8/2015. PMID: 26308668.
2. Aloia TA. Insights into ALPPS. Eur J Surg Oncol 41(5):610-1, 5/2015. e-Pub 2/2015. PMID: 25716333.
3. Ganai S, Thirunavukarasu P, Aloia TA, Choti MA. Timing of Therapies for Patients with Resectable Hepatic Colorectal Metastases. ASCO Connection, 4/2015.
4. Buell J, Geller D, Asbun H, Aloia TA, Tsung A, Jarnagin W. On the Spot: Developments in Approaches to Liver Resection. General Surgery News 41(09):2-11, 9/2014.
5. Cooper AB, Aloia TA. Managing Disappearing Liver Metastases Following Chemotherapy. Current Colorectal Cancer Reports. e-Pub 4/2014.
6. Tzeng CW, Aloia TA. Colorectal Liver Metastases. J Gastrointest Surg 17(1):195-202, 1/2013. e-Pub 10/2012. PMID: 23054896.
7. Andreou A, Aloia TA, Brouquet A, Vauthey JN. Recent advances in the curative treatment of colorectal liver metastases. Gastrointest Cancer Res 4(4 Suppl 1):S2-8, 7/2011. PMCID: PMC3283006.
8. Aloia TA, Fahy BN. Chemotherapy-associated hepatotoxicity: How concerned should we be? Expert Rev Anticancer Ther 10(4):521-27, 4/2010. PMID: 20397917.
9. Aloia TA, Fahy BN. Chemotherapy-associated liver injury: Does it really matter? Current Colorectal Cancer Reports 5:108-13, 2009.
10. Adam R, Miller R, Pitombo M, Wicherts DA, de Haas RJ, Bitsakou G, Aloia TA. Two Stage Hepatectomy Approach for Initially Unresectable Colorectal Hepatic Metastases. Surg Oncol Clin N Am 16(3):525-36, viii, 7/2007. PMID: 17606192.
11. Aloia TA, Adam R, Abdalla EK, Azoulay D, Curley S, Vauthey JN, Castaing D. Evidence for Resection of Colorectal Cancer. Current Colorectal Cancer Reports 2, 1/2006.
12. Aloia TA, Adam R, Azoulay D, Bismuth H, Castaing D. Long-term Results of Hepatic Resection Following, Conversion of Initially Unresectable Colorectal Metastases with Systemic Chemotherapy. Current Colorectal Cancer Reports 2, 1/2006.

Editorials

1. Aloia, TA. Is PVE vs. ALPPS Debatable? JAMA Surgery. In Press.
2. Aloia TA. Adjuvant Surgery for Breast Cancer Liver Metastases. Commentary on "Liver resection and local ablation of breast cancer liver metastases-A systematic review". Breast Diseases: A Year Book Quarterly 23(2):169-171, 2012.
3. Aloia TA, Vauthey JN. Management of colorectal liver metastases: past, present, and future. Updates Surg 63(1):1-3, 3/2011. PMID: 21331669.
4. Aloia TA. Curative therapy for HCC: No one size (modality) fits all. [Editorial to Jarnagin W, Chapman WC, Curley SA, D'Angelica M, Dixon E, Rosen C, et al. Surgical Treatment of Hepatocellular Carcinoma: Expert Consensus Statement]. HPB, 2010.
5. Aloia TA. Predicting outcome in complex cancer surgery. [Editorial to Al-Rafaie, Waddah, et al. Assessment of ACS NSQIP's Predictive Ability for Adverse Events after Major Cancer Surgery. Ann Surg Oncol 17:2274-82, 2010]. Ann Sug Oncol 17:2260-61, 2010.
6. Aloia TA, Lee JE, Vauthey JN, Abdalla EK, Wolfe RA, Crane RH, Evans DB, Pisters PWT. Continuing Medical Education (CME) Featured Article: Impact of prolonged recovery after pancreaticoduodenectomy on delivery of adjuvant therapy to patients with pancreatic adenocarcinoma. J Am Coll Surg 204:522-3, 2007.

Book Chapters

1. Fuks D, Aloia TA, Gayet B. Enhanced Recovery After HPB Surgery. In: Laparoscopic Liver, Pancreas and Biliary Surgery: Textbook and Illustrated Video Atlas. In Press.
2. Ismael H, Aloia TA. Management of Testicular Cancer Liver Metastases. In: Noncolorectal Non-Neuroendocrine Liver Tumors. Ed(s) Isidora Dicarlo. Springer. In Press.
3. Aloia TA. Minimally Invasive Liver Surgery: Indications and Contraindications. In: Laparoscopic Liver, Pancreas and Biliary Surgery: Textbook and Illustrated Video Atlas. In Press.
4. You YN, Eng C, Aloia TA. Multidisciplinary Management of Stage IV Disease. In: Seminars in Colon and Rectal Surgery: Colon Cancer Issue. In Press.
5. Aloia TA, Vauthey JN. Hepatic Metastasis from Colorectal Cancer. In: Blumgart’s Surgery of the Liver, Biliary Tract, and Pancreas. 6th Edition Elsevier, 2016.
6. Thirunavukarasu P, Aloia TA. Preoperative assessment and optimization of the future liver remnant. In: Surg Clin North Am. 96, 2. Ed(s) Cho C, 197-205, e-Book 2016. ISBN: 27017859.
7. Shindoh J, Madoff DC, Aloia TA, Vauthey JN. Preoperative Portal Vein Embolization: Technique and Results. In: Blumgart's Surgery of the Liver, Biliary Tract, and Pancreas. 6th Edition Elsevier, 2016.
8. Aloia TA. Benign Liver Tumors. In: Clinical Decision Support System on Surgery, 2015.
9. Aloia TA, Day R. Managing Early and Late Postoperative Complications following Gastric Surgery. In: Gastric Cancer Principles and Practice, 2015.
10. Day R and Aloia TA. Preoperative considerations for major hepatectomy. In: Patologia Del Higado, Via Bilar Y Pancreas, Principios y Practica, 2015.
11. Fuks D, Aloia TA, Gayet B. In: Laparoscoic Management of Hepato-Pancreato-Biliary (HPB) Diseases, 2014.
12. Aloia TA. Indications and Contraindications to laparoscopic liver surgery. In: Laparoscopic Liver, Pancreas, Biliary Surgery: Textbook and Atlas, 2014.
13. Tzeng CW, Aloia TA. Complications of Liver Surgery Including Hepatic Insufficiency. In: The Handbook of Hepatobiliary and Pancreatic Surgery, 2013.
14. Cooper AB, AloiaTA, Vauthey JN, Curley SA. Controversies in Advanced Disease-Surgical Approcaches for Metastatic Resection. In: Surgical Treatment of Colorectal Liver Mets, 2013.
15. Aloia TA, Gaber OA, Ghobrial RM. Liver Transplant for Hepatocellular Carcinoma. In: Hepatocellular Carcinoma, 219-238, 2011.
16. Vauthey JN, Pawlik TM, Abdalla EK, Aloia TA. Intrahepatic Bile Duct Cancer Staging. In: AJCC Cancer Staging Manual, 7th, 201-210, 2009.
17. Aloia TA. Non-Colorectal Gastrointestinal Liver Metastases. In: Liver Metastases, 169-178, 2009.
18. Aloia TA, Crane OH, Vauthey JN. Gallbladder Carcinoma. In: Textbook of Hepatology: From Basic Science to Clinical Practice, 3rd. Ed(s) Rodes J, Benhamou JP, Rizzetto M, Reichen J, Blei A (ed), 1575-1582, 2006.
19. Aloia TA, Gershenwald JE. Management of Early-Stage Cutaneous Melanoma. In: Current Problems in Surgery. Ed(s) Wells SA (ed), 455-534, 2004.
20. Aloia TA, Harpole DW. Embryology of the Lung. In: General Thoracic Surgery, 6th. Ed(s) Shields Tw, LoCicero J, Poon RB (eds). Lippincott, Williams, and Wilkins, Inc. Philadelphia, 16-28, 2003.
21. Aloia TA, Harpole DW. Embryology of the Lung. In: General Thoracic Surgery, 5th. Ed(s) Shields TW, LoCicero J, Ponn RB (eds). Lippincott, Williams, and Wilkins: Philadelphia, 15-26, 1999.

Letters to the Editor

1. Aloia TA, Vauthey JN. Reply: Air Leak Test, Two Hands Are Better Than None. J Am Coll Surg 218(5):1078-9, 5/2014. PMID: 24745576.
2. Aloia TA, Vauthey JN. Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS): What is Gained and What is Lost? Ann Surg 256(3):e9; author reply e16-9, 9/2012. PMID: 22868369.

Manuals, Teaching Aids, Other Teaching Publications

1. Cooper AB, Habra MA, Grubbs EG, Bednarski BK, Ying AK, Perrier ND, Lee JE, Aloia TA. Does laparoscopic adrenalectomy jeopardize oncologic outcomes for patients with adrenocortical carcinoma. Learning Management System: SAGES University, 1/2014.
2. Aloia TA. Surgical Oncology Ultrasound Training Curriculum, The University of Texas MD Anderson Cancer Center, 2013.
3. Aloia TA. Complications in General Surgery In: Pocket Surgery. Lippincott, Williams and Wilkins, Inc. Philadelphia, 1/2002.

Last updated: 6/6/2016